Schedule 13D ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2016-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,529,120
Percent of class
4.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-076141
Form type
SC 13D/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Jan 20, 2016
Reporting period
Jan 08, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub